22157.jpg
Insights on the Biosimulation Global Market to 2026 - Featuring Certara, Evidera and Gendata Among Others
06 janv. 2022 03h58 HE | Research and Markets
Dublin, Jan. 06, 2022 (GLOBE NEWSWIRE) -- The "Biosimulation Market Research Report by Product & Service, Delivery Model, End-user, Application, and Region - Global Forecast to 2026 - Cumulative...
22157.jpg
Global Biosimulation Market Research Report 2021-2028 - Surging Demand for Biosimulation Software & Services due to their Higher Cost-Efficiency
30 déc. 2021 07h48 HE | Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Global Biosimulation Market Size, Share & Trends Analysis Report by Product (Software, Services), by Application (Drug Development, Drug...
Certara Logo White Background.png
Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
21 déc. 2021 08h00 HE | Certara
PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has renewed and...
Certara Logo White Background.png
Certara Announces Release of Pinnacle 21 Enterprise Software
13 déc. 2021 08h00 HE | Certara
PRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release of Pinnacle 21 Enterprise 5.1.0, which updates...
Certara Logo White Background.png
Certara to Host Investor Day on December 15, 2021
08 déc. 2021 17h00 HE | Certara
PRINCETON, N.J., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, will host an Investor Day on Wednesday, December 15, 2021 from 3:00 PM to 6:00 PM...
Certara Logo White Background.png
Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances
02 déc. 2021 08h00 HE | Certara
PRINCETON, N.J., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Simulator Version 21, which updates the...
Certara Logo White Background.png
Certara Announces Closing of Public Offering of Common Stock
22 nov. 2021 17h45 HE | Certara
PRINCETON, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000...
22157.jpg
Global Biosimulation Global Market (2021 to 2030) - Featuring Certara, Dassault and Simulations Plus Among Others
18 nov. 2021 07h28 HE | Research and Markets
Dublin, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The "Biosimulation Global Market Report 2021: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering. This report...
Certara Logo White Background.png
Certara Appoints James E. Cashman III as Chairman of Board of Directors
08 nov. 2021 16h30 HE | Certara
PRINCETON, N.J., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that James E. Cashman III, a current Board member, will be...
Certara Logo White Background.png
Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
03 nov. 2021 08h00 HE | Certara
PRINCETON, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William F. Feehery, Chief Executive Officer, and Andrew...